Predictors of relapse following transition to ofatumumab in relapsing-remitting multiple sclerosis.

Reardon P, Zhong M, Horakova D, Kermode AG, Fabis-Pedrini M, Vachova M, Prevost J, Lechner-Scott J, Van Der Walt A, Pavelek Z, et al.